Seller record · Telehealth service

InjectCo

Fails 3 of 8 criteria. S3, pharmacy identification: No filling pharmacy is named. The program, semaglutide and tirzepatide pages refer only to a licensed 503B pharmacy and to regulated pharmacy partners. 2 more criteria also fail; see the table below.

At a glance

InjectCoTelehealth service

5/8criteria passed
Price
Semaglutide $249 or $425 a month by page, tirzepatide $425
Sells
compounded semaglutide, sublingual semaglutide drops, and 5 more
FDA letters
None on file
Visit InjectCoSee all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A Texas medical aesthetics chain run by nurse injectors that also sells an online weight loss program with compounded semaglutide injections, semaglutide drops and compounded tirzepatide shipped from a 503B pharmacy, and in-clinic sermorelin, NAD+ and GHK-Cu. Care starts with an online evaluation, and no pharmacy is named.

Operating entity No legal entity name appears in the footer, in the terms of service or in the privacy policy, which name the company only as InjectCo.

Dispositions

CodeCriterionDispositionWhere it appears
S1Prescriber requirementPASSInjectCo's compounded semaglutide online page; InjectCo's online weight loss medication page
S2Prescription gatingPASSInjectCo's compounded semaglutide online page; InjectCo's online weight loss medication page; InjectCo's terms of service page
S3Pharmacy identificationFAILInjectCo's online weight loss medication page; InjectCo's tirzepatide weight loss treatment page
S4Compounding disclosureFAILInjectCo's tirzepatide weight loss treatment page; InjectCo's website; InjectCo's compounded semaglutide online page
S5Analytical documentationFAILInjectCo's online weight loss medication page; InjectCo's premium peptide therapy page; InjectCo's terms of service page
S6Business addressPASSInjectCo's terms of service page; InjectCo's privacy policy
S7Price disclosurePASSInjectCo's compounded semaglutide online page; InjectCo's online weight loss medication page; InjectCo's pricing page; InjectCo's tirzepatide weight loss treatment page
S8Enforcement statusPASSFDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed medical provider reviews each online evaluation and decides whether compounded semaglutide or tirzepatide is clinically appropriate, and the program pages say evaluations are done by nurse injectors and physician assistants under a licensed medical director.Source: InjectCo's compounded semaglutide online page; InjectCo's online weight loss medication page.
S2PASSThe semaglutide and program pages say care starts with an online health evaluation that a licensed provider assesses before any treatment plan, and no page sells the medication into a cart or describes a payment step before that evaluation.Source: InjectCo's compounded semaglutide online page; InjectCo's online weight loss medication page; InjectCo's terms of service page.
S3FAILNo filling pharmacy is named. The program, semaglutide and tirzepatide pages refer only to a licensed 503B pharmacy and to regulated pharmacy partners.Source: InjectCo's online weight loss medication page; InjectCo's tirzepatide weight loss treatment page.
S4FAILThe tirzepatide page sells the compounded tirzepatide program, sourced from a 503B pharmacy, under a banner saying the clinic uses only FDA-approved products, and the home page carries an FDA-approved products badge. The semaglutide page states that compounded medications are not FDA-approved, which does not withdraw the claim on the tirzepatide page.Source: InjectCo's tirzepatide weight loss treatment page; InjectCo's website; InjectCo's compounded semaglutide online page.
S5FAILNo certificate of analysis or lot document is published on the weight loss pages, the peptide pages, the terms or the privacy policy.Source: InjectCo's online weight loss medication page; InjectCo's premium peptide therapy page; InjectCo's terms of service page.
S6PASS5964 W Parker Rd, Suite 107, Plano, TX 75093, printed as the company's contact address in the terms of service and in the privacy policy. The terms name Texas law.Source: InjectCo's terms of service page; InjectCo's privacy policy.
S7PASSCompounded semaglutide at $249 a month on the semaglutide page, while the weight loss program page, the semaglutide drops page and the pricing page put the compounded semaglutide program, the drops and the compounded tirzepatide program at $425 a month, covering telehealth visits, medication and delivery. The pricing page also lists a 6 to 8 month program at $1,800.Source: InjectCo's compounded semaglutide online page; InjectCo's online weight loss medication page; InjectCo's pricing page; InjectCo's tirzepatide weight loss treatment page.
S8PASSNo FDA warning letter names InjectCo, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, sublingual semaglutide drops, compounded tirzepatide, sermorelin, NAD+, GHK-Cu, glutathione.

Visit InjectCo

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.